CLINICAL_TRIALS trial_result · 2020-01-27

Clinical Trial Update: Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus [Phase 2]

Phase 2 proof-of-concept study for BT063 in systemic lupus erythematosus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Biotest | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2020-01-27